Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid Tumors

Clinical trial NCT03510104 · COMPLETED

Trial details

NCT number: NCT03510104
Sponsor: Meryx, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer Metastatic Cancer Neoplasms Neoplasm Metastasis Neoplastic Processes Pathologic Processes

Start date: 2018-05-22
Primary completion: 2025-12-31
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.